ID

39865

Description

ImmunoTEP au 68-Ga- IMP-288 for Patients With a Recurrence of HER2 Negative Breast Carcinoma Expressing CEA; ODM derived from: https://clinicaltrials.gov/show/NCT01730612

Lien

https://clinicaltrials.gov/show/NCT01730612

Mots-clés

Versions (1)
  1. 25/02/2020 25/02/2020 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

25 février 2020

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility HER2 Negative Breast Carcinoma Expressing CEA NCT01730612

Anglais

Eligibility HER2 Negative Breast Carcinoma Expressing CEA NCT01730612

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
breast carcinoma, her2 + (dako) and her2 + (fish) metastatic at least after treatment with current consensus
Description

HER2-positive carcinoma of breast metastatic FISH | Status post Treatment

Type de données

boolean

Alias
UMLS CUI [1,1]
C1960398
UMLS CUI [1,2]
C1522484
UMLS CUI [1,3]
C0162789
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C0087111
≥ 18 years
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
negative pregnancy test for women of childbearing age. women of childbearing age should take effective contraception continuously for 3 months.
Description

Childbearing Potential Pregnancy test negative | Childbearing Potential Contraceptive methods

Type de données

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0427780
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
karnofsky ≥ 70 or ecog 0-1
Description

Karnofsky Performance Status

Type de données

boolean

Alias
UMLS CUI [1]
C0206065
life expectancy of at least 6 months
Description

Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
ace of the tumor by immunohistochemistry or positive plasma cea ≥ 10 ng / ml
Description

ACE Tumor Immunohistochemistry | Plasma CEA measurement

Type de données

boolean

Alias
UMLS CUI [1,1]
C0022709
UMLS CUI [1,2]
C0027651
UMLS CUI [1,3]
C0021044
UMLS CUI [2,1]
C0032105
UMLS CUI [2,2]
C0201933
at least one measurable lesion on ct
Description

Measurable lesion Quantity CT

Type de données

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0040405
creatinine < 2.5
Description

Creatinine measurement, serum

Type de données

boolean

Alias
UMLS CUI [1]
C0201976
informed consent signed
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
social insurance
Description

Social insurance

Type de données

boolean

Alias
UMLS CUI [1]
C0037435
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnancy or breastfeeding
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
serious illness or co-morbidity risk assessed
Description

Illness Serious | Comorbidity Risk Assessed

Type de données

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205404
UMLS CUI [2,1]
C0009488
UMLS CUI [2,2]
C0035647
UMLS CUI [2,3]
C1516048
history of cancer within 5 years except skin cancer other than melanoma or carcinoma in situ of the cervix
Description

Malignant Neoplasms | Exception Skin carcinoma | Exception Carcinoma in situ of uterine cervix

Type de données

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0699893
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0851140
presence of anti-antibodies in patients who have previously received antibodies
Description

Anti-Antibodies | Patients Antibodies Previous

Type de données

boolean

Alias
UMLS CUI [1]
C1624602
UMLS CUI [2,1]
C0030705
UMLS CUI [2,2]
C0003241
UMLS CUI [2,3]
C0205156
known hypersensitivity to antibodies or proteins
Description

Hypersensitivity Antibodies | Protein allergy

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0003241
UMLS CUI [2]
C1112677
intellectual disability to sign the informed consent
Description

Intellectual Disability | Informed Consent Unable

Type de données

boolean

Alias
UMLS CUI [1]
C3714756
UMLS CUI [2,1]
C0021430
UMLS CUI [2,2]
C1299582
diabetes
Description

Diabetes Mellitus

Type de données

boolean

Alias
UMLS CUI [1]
C0011849
persons protected by law
Description

Protection of patient Legal

Type de données

boolean

Alias
UMLS CUI [1,1]
C0412786
UMLS CUI [1,2]
C1301860
Retour au début de la page

Similar models

Eligibility HER2 Negative Breast Carcinoma Expressing CEA NCT01730612

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
HER2-positive carcinoma of breast metastatic FISH | Status post Treatment
Item
breast carcinoma, her2 + (dako) and her2 + (fish) metastatic at least after treatment with current consensus
boolean
C1960398 (UMLS CUI [1,1])
C1522484 (UMLS CUI [1,2])
C0162789 (UMLS CUI [1,3])
C0231290 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
Age
Item
≥ 18 years
boolean
C0001779 (UMLS CUI [1])
Childbearing Potential Pregnancy test negative | Childbearing Potential Contraceptive methods
Item
negative pregnancy test for women of childbearing age. women of childbearing age should take effective contraception continuously for 3 months.
boolean
C3831118 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
Karnofsky Performance Status
Item
karnofsky ≥ 70 or ecog 0-1
boolean
C0206065 (UMLS CUI [1])
Life Expectancy
Item
life expectancy of at least 6 months
boolean
C0023671 (UMLS CUI [1])
ACE Tumor Immunohistochemistry | Plasma CEA measurement
Item
ace of the tumor by immunohistochemistry or positive plasma cea ≥ 10 ng / ml
boolean
C0022709 (UMLS CUI [1,1])
C0027651 (UMLS CUI [1,2])
C0021044 (UMLS CUI [1,3])
C0032105 (UMLS CUI [2,1])
C0201933 (UMLS CUI [2,2])
Measurable lesion Quantity CT
Item
at least one measurable lesion on ct
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0040405 (UMLS CUI [1,3])
Creatinine measurement, serum
Item
creatinine < 2.5
boolean
C0201976 (UMLS CUI [1])
Informed Consent
Item
informed consent signed
boolean
C0021430 (UMLS CUI [1])
Social insurance
Item
social insurance
boolean
C0037435 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
pregnancy or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Illness Serious | Comorbidity Risk Assessed
Item
serious illness or co-morbidity risk assessed
boolean
C0221423 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0009488 (UMLS CUI [2,1])
C0035647 (UMLS CUI [2,2])
C1516048 (UMLS CUI [2,3])
Malignant Neoplasms | Exception Skin carcinoma | Exception Carcinoma in situ of uterine cervix
Item
history of cancer within 5 years except skin cancer other than melanoma or carcinoma in situ of the cervix
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
Anti-Antibodies | Patients Antibodies Previous
Item
presence of anti-antibodies in patients who have previously received antibodies
boolean
C1624602 (UMLS CUI [1])
C0030705 (UMLS CUI [2,1])
C0003241 (UMLS CUI [2,2])
C0205156 (UMLS CUI [2,3])
Hypersensitivity Antibodies | Protein allergy
Item
known hypersensitivity to antibodies or proteins
boolean
C0020517 (UMLS CUI [1,1])
C0003241 (UMLS CUI [1,2])
C1112677 (UMLS CUI [2])
Intellectual Disability | Informed Consent Unable
Item
intellectual disability to sign the informed consent
boolean
C3714756 (UMLS CUI [1])
C0021430 (UMLS CUI [2,1])
C1299582 (UMLS CUI [2,2])
Diabetes Mellitus
Item
diabetes
boolean
C0011849 (UMLS CUI [1])
Protection of patient Legal
Item
persons protected by law
boolean
C0412786 (UMLS CUI [1,1])
C1301860 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial